Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk

Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, Tybulewicz VL, Watson SP

(2007), Arterioscler Thromb Vasc Biol, 27(2), 422-9

Antiplatelet therapy: present status and future prospects

Hamilton JR, Kaplan Z, Jackson SP, Opat S

(2007), Expert Opin Drug Dis, 2(8), 1035-40

Association between osteopontin and human abdominal aortic aneurysm

Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE

(2007), Arterioscler Thromb Vasc Biol, 27(3), 655-60

PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis

Ferguson GJ, Milne L, Kulkarni S, Sasaki T, Walker S, Andrews S, Crabbe T, Finan P, Jones G, Jackson S, Camps M, Rommel C, Wymann M, Hirsch E, Hawkins P, Stephens L

(2007), Nat Cell Biol, 9(1), 86-91

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foà R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD; Multiple Myeloma (010) Study Investigators

(2007), N Engl J Med, 357(21), 2123-32

Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains

Dawson MA, Patil S, Spencer A

(2007), Haematologica, 92(1), 143-4

Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor

Daniel PB, Lux W, Samson AL, Schleuning WD, Niego B, Weiss TW, Tjärnlund-Wolf A, Medcalf RL

(2007), FEBS J, 274(9), 2411-23

Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling

Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Grønning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N, Shepherd PR

(2007), Biochem J, 404(3), 449-58

Genotype and adverse drug reactions to warfarin

Byron KA, Dear AE

(2007), Med J Aust, 187(1), 61-2

Evaluation of protease-activated receptor 2 in murine models of arthritis

Busso N, Frasnelli M, Feifel R, Cenni B, Steinhoff M, Hamilton J, So A

(2007), Arthritis Rheum, 56(1), 101-7

Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma

Baulch-Brown C, Molloy TJ, Yeh SL, Ma D, Spencer A

(2007), Leuk Res, 31(3), 341-52

Immune recovery uveitis in an HIV-negative individual

Baker ML, Allen P, Shortt J, Lewin SR, Spencer A

(2007), Clin Experiment Ophthalmol, 35(2), 189-90

Novel role for insulin as an autocrine growth factor for malignant brain tumour cells

Arcaro A, Doepfner KT, Boller D, Guerreiro AS, Shalaby T, Jackson SP, Schoenwaelder SM, Delattre O, Grotzer MA, Fischer B

(2007), Biochem J, 406(1), 57-66

Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?

Dawson MA, Avery S, McQuilten ZK, Bailey MJ, Shortt J, Polizzotto MN, Wood EM, Cole-Sinclair MF

(2007), Haematologica, 92(7), 996-7

Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma

Hiwase DK, Bollard G, Hiwase S, Bailey M, Muirhead J, Schwarer AP

(2007), Cytotherapy, 9(6), 539-47

Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia target

Etto TL, Stewart LA, Muirhead J, Bailey M, Schwarer AP

(2007), Tissue Antigens, 69(1), 56-61

Visualizing thrombus formation in vivo: Current limitations and future prospects

Woollard KJ, Nesbitt WS, Harper IS, Sturgeon SA, Jackson SP

(2006), Int Rev Thrombosis, 1, 34-42

Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion

Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, Chin-Dusting J

(2006), Circ Res, 98(1), 149-56

Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma

Wolf M, Bentley M, Marlton P, Horvath N, Lewis ID, Spencer A, Herrmann R, Arthur C, Durrant S, van Kerkhoven M, MacMillan J, Mrongovius R

(2006), Leuk Lymphoma, 47(11), 2344-50

Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo

Weiss TW, Samson AL, Niego B, Daniel PB, Medcalf RL

(2006), FASEB J, 20(13), 2369-71

42 43 44 45 46